These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16408127)

  • 1. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.
    Berthier CC; Lods N; Joosten SA; van Kooten C; Leppert D; Lindberg RL; Kappeler A; Raulf F; Sterchi EE; Lottaz D; Marti HP
    Kidney Int; 2006 Jan; 69(2):358-68. PubMed ID: 16408127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation.
    Berthier C; Marti HP
    Swiss Med Wkly; 2006 Dec; 136(49-50):789-94. PubMed ID: 17299656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental heart transplantation: effect of cyclosporine on expression and activity of metzincins.
    Berthier CC; Pally C; Weckbecker G; Raulf F; Rehrauer H; Wagner U; Le Hir M; Marti HP
    Swiss Med Wkly; 2009 Apr; 139(15-16):233-40. PubMed ID: 19418307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
    Shek FW; Benyon RC; Walker FM; McCrudden PR; Pender SL; Williams EJ; Johnson PA; Johnson CD; Bateman AC; Fine DR; Iredale JP
    Am J Pathol; 2002 May; 160(5):1787-98. PubMed ID: 12000730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation.
    Berthier C; Marti HP
    Swiss Med Wkly; 2007 Mar; 137 Suppl 155():109S-114S. PubMed ID: 17874514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
    J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection.
    Wu GD; Tuan TL; Bowdish ME; Jin YS; Starnes VA; Cramer DV; Barr ML
    Transplantation; 2003 Aug; 76(3):609-14. PubMed ID: 12923453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of transforming growth factor-beta and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine.
    Khanna AK; Hosenpud JS; Plummer MS; Hosenpud JD
    Transplantation; 2002 May; 73(10):1543-9. PubMed ID: 12042638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of ADAM10, ADAM17, MMP-2 and MMP-9 expression with media degeneration features CaCl2-induced thoracic aortic aneurysm in a rat model.
    Geng L; Wang W; Chen Y; Cao J; Lu L; Chen Q; He R; Shen W
    Exp Mol Pathol; 2010 Aug; 89(1):72-81. PubMed ID: 20621845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
    Ermolli M; Schumacher M; Lods N; Hammoud M; Marti HP
    Transpl Immunol; 2003; 11(2):137-45. PubMed ID: 12799196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof].
    Zou HQ; Yao J; Wang YX; Wang J; Li D; Wang P
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):981-5. PubMed ID: 16061007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14.
    Filanti C; Dickson GR; Di Martino D; Ulivi V; Sanguineti C; Romano P; Palermo C; Manduca P
    J Bone Miner Res; 2000 Nov; 15(11):2154-68. PubMed ID: 11092396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.